SCHEMBL6081371

SCHEMBL6081371

CCOC(=O)C(C)(C)Oc1cccc(CC(=O)OCc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.61
PPARG P37231 5/20 0.61
ALDH1A1 P00352 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
FBP1 P09467 5/20 0.49
ABCB11 O95342 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
HTR2A P28223 1/20 0.47
PMP22 Q01453 1/20 0.47
GRM2 Q14416 1/20 0.43
LTB4R Q15722 1/20 0.42
LTB4R2 Q9NPC1 1/20 0.42
MMP8 P22894 1/20 0.41
ENPP2 Q13822 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6080934 0.88 ALDH1A1 (0.57) PPARAPPARGALDH1A1MAPK1L3MBTL1
SCHEMBL5795465 0.88 ALDH1A1 (0.56) PPARAPPARGALDH1A1MAPK1L3MBTL1
SCHEMBL6081046 0.86 PPARA (0.67) PPARAPPARGMAPK1L3MBTL1FBP1
SCHEMBL6544041 0.84 PPARA (0.58) PPARAPPARGFBP1ABCB11CYP1A2
SCHEMBL6080910 0.83 ALDH1A1 (0.51) PPARAPPARGALDH1A1MAPK1L3MBTL1
SCHEMBL6543477 0.83 PPARA (0.66) PPARAPPARGMAPK1L3MBTL1FBP1
SCHEMBL6080648 0.82 CYP1A2 (0.47) PPARAPPARGALDH1A1MAPK1L3MBTL1
SCHEMBL22070486 0.81 PPARA (0.55) PPARAPPARGFBP1ABCB11CYP1A2
SCHEMBL6093013 0.81 PPARA (0.70) PPARAPPARGMAPK1L3MBTL1FBP1
SCHEMBL13141027 0.80 PPARA (0.66) PPARAPPARGMAPK1L3MBTL1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses GENFIT (FR) 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079696-A1 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses AADAC, NAT1, PARN PPARA 425/4885PPARG 769/4885ALDH1A1 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.